Vitamin D3 for Life

Live Enlightened

Article

Physiological regulation of clearance and feedback: Study Summary

Previous related pagePhysiological regulation of clearance and feedback: Full Evidence ReviewNext related pageRenal and Intestinal CYP24A1 Regulation: Full Evidence Review
Study at a glance

How do hormones control vitamin D activation and breakdown?

This page explains how hormone signals control both the activation and breakdown of vitamin D. Researchers studied the parts of DNA that control these processes and removed selected control regions or enzymes to test their roles. Most of these experiments used laboratory models rather than people.

Did the kidneys and intestine control vitamin D in the same way?

Active vitamin D increases production of CYP24A1, an enzyme that helps break it down. This allows the active hormone to limit its own effects. In the kidney, parathyroid hormone usually increases vitamin D activation and reduces breakdown. Another hormone, FGF23, usually shifts the balance in the opposite direction. The studies also showed that control differs between tissues. The kidney helps control vitamin D throughout the body, while the intestine can control vitamin D activity within its own tissue.

Can these vitamin D control findings be applied to people?

The response to FGF23 depends on the amount given, timing and tissue being studied. The rules seen in the kidney do not apply in exactly the same way everywhere else. Changes within the intestine need not produce the same blood changes as changes in the kidney. These findings explain how activation and breakdown work together, but they do not show that people will have effects of the same size as those seen in laboratory models.

Read the full article below ↓

What question does this evidence answer?

Vitamin D clearance changes in response to endocrine signals and tissue context. The central question is how CYP24A1 is regulated relative to CYP27B1, the activation enzyme, and how that balance controls active vitamin D availability within the wider vitamin D enzyme pathways.

What did the researchers find?

Calcitriol stimulates CYP24A1 through VDR/RXR-responsive regulatory regions, forming direct negative feedback. In the kidney, PTH generally suppresses Cyp24a1 while increasing Cyp27b1, whereas FGF23 usually drives the system in the opposite direction.

Genomic and enhancer-deletion studies show that kidney and nonrenal tissues do not use identical regulatory architecture. Tissue-specific deletion experiments also separate systemic renal control from local intestinal CYP24A1 activity.

Why does this matter?

Activation and degradation are regulated together. A rise in active-hormone signalling can induce its own catabolic machinery, while PTH and FGF23 shift the renal balance according to mineral-homeostatic needs. Clearance therefore helps determine both how much active vitamin D is available and how long the signal persists, which is one reason Vitamin D Thresholds vs Targets requires physiological context rather than a single isolated number.

What are the important qualifications?

  • FGF23 responses are not unconditional; dose, timing and tissue context matter.
  • Renal regulation should not be projected unchanged onto every nonrenal tissue.
  • Local intestinal CYP24A1 activity can matter without producing the same systemic effect as renal CYP24A1.
  • Most causal regulatory experiments are in model systems, so quantitative human equivalence should not be assumed.

Primary evidence and publication details

Meyer MB, Lee SM, Carlson AH, et al. A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. J Biol Chem. 2019;294:14467-14481.

Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. J Biol Chem. 2010;285:15599-15610.

Yoon SH, Meyer MB, Arevalo C, et al. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023;133:e163627.

Fuchs MAA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. J Clin Invest. 2025;135:e179882.

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. 2018.

Related reading

Original sources

Source

A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis

The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.

Publication details

Yoon SH, Meyer MB, Arevalo C, et al. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023;133:e163627.

Read more →
Source

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.

Publication details

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. 2018.

Read more →